Pharmaceuticals for the purpose of treating life-threatening diseases; pharmaceuticals for use in the fields of biotechnology and immune therapeutics; pharmaceutical products, namely, innate immunity cell-based therapeutics; pharmaceuticals for the treatment of infectious disease, autoimmunity, neurodegeneration, and aging; pharmaceuticals for addressing underlying innate immune dysfunction, including in connection with infectious diseases, autoimmune diseases, neurologic diseases, cancer, Pa...